Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023

Yıl: 2023 Cilt: 36 Sayı: 2 Sayfa Aralığı: 86 - 123 Metin Dili: Türkçe DOI: 10.36519/kd.2023.4576 İndeks Tarihi: 03-07-2023

Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023

Öz:
Bruselloz, dünyada ve ülkemizde çok yaygın olarak görülmesine rağmen hastalığın tanı ve tedavisini yönlendirmede kullanılabilecek kanıta dayalı bir rehber bulunmamaktadır. Bu rehber, brusellozun tanı ve tedavisi ile ilgilenen farklı uzmanlık alanlarından hekimlere kanıta dayalı öneriler sunmak üzere Türk Klinik Mikrobiyoloji ve İnfeksiyon Has- talıkları Derneği tarafından hazırlanmıştır. Rehberin hazırlanmasında, ABD İnfeksiyon Hastalıkları Derneği (IDSA)’nin Klinik Uygulama Rehberi Geliştirme Kı- lavuzu önerileri esas alınmıştır. Rehberi hazırlayan grup üyeleri tarafından, bruselloz tanı ve tedavisinde önemli olduğu düşünülen 20 soru belirlenmiş ve PICO [hasta/popülasyon (P), müdahale/indikator (I), karşılaştırma/kontrol (C), sonuç (O)] formatında oluşturulan bu sorulara yanıt verebilecek yayınlar, ULAKBİM TR Dizin, PubMed ve Cochrane veritabanlarından, tarih kısıtlaması olmadan taranmıştır. Her bir PICO sorusu ve her bir ayrı sonlanım için kanıtların derecelendirilmesinde ve önerilerin gücünün belirlenmesinde “Grading of Recommendations, Assessment, Develop- ment and Evaluation (GRADE) Working Group” yöntemi kullanılmıştır. PICO sorularına yanıt oluşturabilecek şekilde karşılaştırmalı klinik araştırmaların olması halinde bunların meta-analizleri, olmaması halindeyse olgu sunumları ve olgu serilerinden elde edilen verilerle “individual participant data” (IPD) meta-analizleri yapılmıştır. Önerilerin yeni çalışmaların sonuçları doğrultusunda belli aralıklarla güncellenmesi planlanmaktadır.
Anahtar Kelime:

The Turkish Clinical Microbiology and Infectious Diseases Society (KLİMİK) Evidence-Based Guideline for the Diagnosis and Treatment of Brucellosis, 2023

Öz:
Although brucellosis is very common in the world and Türkiye, there are no evidence-based guidelines to guide the diagnosis and treatment of the disease. This guide has been prepared by the Turkish Society of Clinical Microbiology and Infectious Diseases to provide evidence-based recommendations to physicians from different specialties interested in the diagnosis and treatment of brucellosis. The recommendations of the Clinical Practice Guide Development Guide of the Infectious Diseases Society of Amer- ica (IDSA) were taken as the basis for preparing this guide. The guideline preparation group determined 20 questions considered to be important in the diagnosis and treatment of brucellosis, and the publications that could answer these questions prepared in PICO (Population/Patient [P], Intervention [I], Comparison [C], Outcome [O]) format, were searched in ULAKBİM Tr Dizin, PubMed, Cochrane databases without date restrictions. The Grading of Recommen- dations, Assessment, Development, and Evaluation (GRADE) Working Group method was used to rank the evidence and determine the strength of the recommendations for each PICO question and for each individual outcome. Me- ta-analyses of comparative clinical studies were performed to answer the PICO questions. Individual participant data (IPD) meta-analyses with data obtained from case reports and case series were conducted in the absence of comparative clinical studies. It is planned to update the recommendations at regular intervals in line with the results of new studies.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Handbook for Clinical Practice Guidelines Development (Version 2.2018) [In- ternet]. Arlington: The Infectious Disease Society of America. [erişim 2 Mayıs 2019]. https://idsocietyorg.app.box.com/s/zumf91rnftiv9xfzos5eot9sg2tgg2fr
  • 2. Disclosure of Interest (Updated February 2021) [Internet]. International Committee of Medical Journal Editors (ICMJE). [erişim 12 Ocak 2023]. https:// www.icmje.org/disclosure-of-interest/
  • 3. Yükseköğretim Kanunu [Internet]. Ankara: T.C. Cumhurbaşkanlığı Mevzuat Bilgi Sistemi. [erişim 12 Ocak 2023]. https://www.mevzuat.gov.tr/mevzuat- metin/1.5.2547.pdf
  • 4. Schünemann H, Brożek J, Guyatt G, Oxman A (eds). Grade Handbook [Inter- net]. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group (www.gradeworkinggroup.org).[erişim 2 Mayıs 2019]. https://gdt.gradepro.org/app/handbook/handbook.html
  • 5. Higgins JP, Altman DG, Gøtzsche PC, et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. [CrossRef]
  • 6. Whiting PF, Rutjes AW, Westwood ME, et al; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-36. [CrossRef]
  • 7. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa scale (NOS) for nonrandomized studies and QUADAS-2 tool for diagnostic test accuracy studies. [Internet]. Ottawa: The Ottowa Hospital Research Institute. [erişim 13 Mayıs 2019]. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • 8. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommen- dations. BMJ. 2008;336(7650):924-6. [CrossRef]
  • 9. Wyatt HV. Lessons from the history of brucellosis. Rev Sci Tech. 2013;32(1):17- 25. [CrossRef]
  • 10. Murray PR, Rosenthal KS, MA Pfaller, et al. Medical Microbiology. 9th ed. Amsterdam: Elsevier Inc., 2021; 293-306.
  • 11. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352(22):2325-36. [CrossRef]
  • 12. Rowlinson MC, Lee P. 16.6 Brucella spp.—Brucellosis. In: Snyder JW, Leber AL, eds. Clinical Microbiology Procedures Handbook. 4th ed. Washington DC: ASM Press, 2016: 16.6.1-16.6.12.
  • 13. Laine CG, Scott HM, Arenas-Gamboa AM. Human brucellosis: Widespread information deficiency hinders an understanding of global disease frequency. PLoS Negl Trop Dis. 2022;16(5):e0010404. [CrossRef]
  • 14. Annual Epidemiological Report for 2020: Brucellosis [Internet]. Solna: European Centre for Disease Prevention and Control (ECDC). [erişim 15 Mayıs 2022]. https://www.ecdc.europa.eu/sites/default/files/documents/AER_2020_Re- port_BRUC.pdf
  • 15. European Food Safety Authority; European Centre for Disease Prevention and Control. The European Union One Health 2020 Zoonoses Report. EFSA J. 2021;19(12):e06971. [CrossRef]
  • 16. Tao Z, Chen Q, Chen Y, et al. Epidemiological characteristics of human bru- cellosis - China, 2016-2019. China CDC Wkly. 2021;3(6):114-9.
  • 17. Musallam II, Abo-Shehada MN, Hegazy YM, Holt HR, Guitian FJ. Systematic review of brucellosis in the Middle East: disease frequency in ruminants and humans and risk factors for human infection. Epidemiol Infect. 2016;144(4):671- 85. [CrossRef]
  • 18. Wang XH, Jiang H. [Global prevalence of human brucellosis]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(10):1717-22. Chinese. [CrossRef]
  • 19. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91-9. [CrossRef ]
  • 20. Bruselloz İstatistik Verileri [Internet]. Ankara: T.C Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Zoonotik ve Vektörel Hastalıklar Daire Başkanlığı. [erişim 15 Ekim 2022]. https://hsgm.saglik.gov.tr/tr/zoonotikvektorel-bruselloz/ istatistik.html
  • 21. Çakır Ş, Yıldırım M. [Control and eradication strategies of brucellosis small ruminants in Turkey]. Dicle Üniv Vet Fak Derg. 2018;(2)98-104. Turkish.
  • 22. Haque N, Bari MS, Hossain MA, et al. An overview of Brucellosis. Mymensingh Med J. 2011;20(4):742-7.
  • 23. Ergönül O, Zeller H, Kiliç S, et al. Zoonotic infections among veterinarians in Turkey: Crimean-Congo hemorrhagic fever and beyond. Int J Infect Dis. 2006;10(6):465-9. [CrossRef]
  • 24. Gül HC, Erdem H. Brucellosis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Churchill Livingstone, 2020: 2753-8.
  • 25. Nicoletti P. Relationship between animal and human disease. In: Young EJ, Corbel MJ, eds. Brucellosis: Clinical and Laboratory Aspects. 1st ed. Boca Raton, Florida: CRC Press, 1989: 41-3.
  • 26. Brucellosis in humans and animals [Internet]. Geneva: World Health Or- ganization. [erişim 14 Mayıs 2022]. https://www.who.int/publications/i/ item/9789241547130
  • 27. Brucellosis Reference Guide 2017 [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC). [erişim 14 Mayıs 2022]. https://www.cdc.gov/ brucellosis/pdf/brucellosi-reference-guide.pdf
  • 28. Bulaşıcı Hastalıkların İhbarı ve Bildirim Sistemi: Standart Tanı, Sürveyans ve Laboratuvar Rehberi, 2004 [Internet]. Ankara T.C. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü. [erişim 14 Mayıs 2022]. https://dosyasb. saglik.gov.tr/Eklenti/1442,bhastaliktedavipdf.pdf?0
  • 29. Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2019;33(1):e00073-19. [CrossRef]
  • 30. Christoforidou S, Kyritsi M, Boukouvala E, et al. Identification of Brucella spp. isolates and discrimination from the vaccine strain Rev.1 by MALDI-TOF mass spectrometry. Mol Cell Probes. 2020;51:101533. [CrossRef]
  • 31. Brucellosis (Brucella spp.): 2010 Case Definition [Internet]. Atlanta: Centers for Disease Control and Prevention. [erişim 14 Mayıs 2022]. https://ndc.services. cdc.gov/case-definitions/brucellosis-2010/
  • 32. WHO recommended strategies for the prevention and control of communicable diseases, 2001 [Internet]. Geneva: World Health Organization (WHO). [erişim 14 Mayıs 2022]. https://apps.who.int/iris/handle/10665/67088
  • 33. Guven T, Ugurlu K, Ergonul O, et al. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis. 2013;56(10):1407-12. [CrossRef]
  • 34. Ceran N, Turkoglu R, Erdem I, et al. Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region. Braz J Infect Dis. 2011;15(1):52-9.
  • 35. Demiraslan H, Metan G, Mese EA, et al. Neurobrucellosis: an evaluation of a rare presentation of brucellosis from a tertiary care centre in Central Anatolia, Turkey. Trop Doct. 2009;39(4):233-5. [CrossRef]
  • 36. Karsen H, Tekin Koruk S, Duygu F, Yapici K, Kati M. Review of 17 cases of neurobrucellosis: clinical manifestations, diagnosis, and management. Arch Iran Med. 2012 Aug;15(8):491-4.
  • 37. Zheng N, Wang W, Zhang JT, et al. Neurobrucellosis. Int J Neurosci. 2018;128(1):55- 62. [CrossRef]
  • 38. Erdem H, Kilic S, Sener B, et al. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study. Clin Microbiol Infect. 2013;19(2):E80-6. [CrossRef]
  • 39. Jiao LD, Chu CB, Kumar CJ, et al. Clinical and laboratory findings of nonacute neurobrucellosis. Chin Med J (Engl). 2015;128(13):1831-3. [CrossRef]
  • 40. Bodur H, Erbay A, Akinci E, Colpan A, Cevik MA, Balaban N. Neurobrucellosis in an endemic area of brucellosis. Scand J Infect Dis. 2003;35(2):94-7. [CrossRef]
  • 41. Demiroğlu YZ, Turunç T, Karaca S, et al. [Neurological involvement in brucellosis; clinical classification, treatment and results]. Mikrobiyol Bul. 2011;45(3):401-10. Turkish.
  • 42. Ibrahimagić OĆ, Smajlović D, Dostović Z, Iljazović A, Kojić B, Zonić L. Neu- robrucellosis and cerebral venous sinus thrombosis: a case report. Acta Clin Belg. 2017;72(5):343-5. [CrossRef]
  • 43. Miguel PS, Fernández G, Vasallo FJ, et al. Neurobrucellosis mimicking cerebral tumor: case report and literature review. Clin Neurol Neurosurg. 2006;108(4):404-6. [CrossRef]
  • 44. Algahtani H, Shirah B, Abdulghani D, Farhan R, Algahtani R. Occupational neurobrucellosis mimicking a brain tumor: A case report and review of the literature. Case Rep Infect Dis. 2017;2017:1434051. [CrossRef]
  • 45. Soares CN, Angelim AIM, Brandão CO, Santos RQ, Mehta R, Silva MTTD. Neurobrucellosis: the great mimicker. Rev Soc Bras Med Trop. 2022;55:e05672021. [CrossRef]
  • 46. Anadure RK, Goel J, Sahu S, Vidhale T. Recurrent encephalopathy with trans- verse myelitis: An uncommon presentation of neurobrucellosis. J Neurosci Rural Pract. 2019;10(4):703-6. [CrossRef]
  • 47. Nepal G, Balayar R, Bhatta S, et al. Neurobrucellosis: A differential not to be missed in patients presenting with neuropsychiatric features. Clin Case Rep. 2021;9(6):e04190. [CrossRef]
  • 48. Seidel G, Pardo CA, Newman-Toker D, Olivi A, Eberhart CG. Neurobrucellosis presenting as leukoencephalopathy: the role of cytotoxic T lymphocytes. Arch Pathol Lab Med. 2003;127(9):e374-7. [CrossRef]
  • 49. Panagariya A, Sharma B, Mathew V. Pseudotumor--like presentation of neu- robrucellosis. J Assoc Physicians India. 2007;55:301-2.
  • 50. Jochum T, Kliesch U, Both R, Leonhardi J, Bär KJ. Neurobrucellosis with thalamic infarction: a case report. Neurol Sci. 2008;29(6):481-3. [CrossRef]
  • 51. Dias MS, Morganho A, Passão V, Aguiar T, Pedrosa R. [Neuro-brucellosis. Report of 8 cases]. Acta Med Port. 1995;8(12):671-5. Portuguese.
  • 52. Malhi AB, Ridal M, Bouchal S, Belahsen MF, El Alami MN. [Neurobrucellosis: a treatable cause of sensorineural hearing loss not to ignore]. Pan Afr Med J. 2015;22:122. French. [CrossRef]
  • 53. Lima JI, Canelas CF, Veiga AS, Carvalho DM. Neurobrucellosis and venous sinus thrombosis: an uncommon association. Rev Soc Bras Med Trop. 2016;49(3):383-5. [CrossRef]
  • 54. Maji S, Manjunath N, Bahubali VH, et al. Neurobrucellosis: A neglected entity? An update from tertiary care Neurocentre of South East Asia. J Neurol Sci. 2020;411:116683. [CrossRef]
  • 55. CLSI. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. 3rd ed. CLSI guideline M45. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.
  • 56. ISO 20776-1:2006: Clinical Laboratory Testing and In Vitro Diagnostic Test Systems—Susceptibility Testing of Infectious Agents and Evaluation of Perfor- mance of Antimicrobial Susceptibility Test Devices—Part 1: Reference Method for Testing the In Vitro Activity of Antimicrobial Agents against Rapidly Growing Aerobic Bacteria Involved in Infectious Diseases. International Organization for Standardization: Geneva, Switzerland, 2006.
  • 57. Tscherne A, Mantel E, Boskani T, et al; EMERGE AST Working Group. Ad- aptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method. Microorganisms. 2022;10(7):1470. [CrossRef]
  • 58. Ariza J, Bosilkovski M, Cascio A, et al; International Society of Chemotherapy; Institute of Continuing Medical Education of Ioannina. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007;4(12):e317. [CrossRef]
  • 59. Roushan MR, Gangi SM, Ahmadi SA. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. Swiss Med Wkly. 2004;134(37-38):564-8. [CrossRef]
  • 60. Akova M, Gür D, Livermore DM, Kocagöz T, Akalin HE. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrob Agents Chemother. 1999;43(5):1298-300. [CrossRef]
  • 61. Atkins HS, Spencer S, Brew SD, et al. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection. Int J Antimicrob Agents. 2010;36(1):66-8. [CrossRef]
  • 62. Solera J, Beato JL, Martínez-Alfaro E, Segura JC, de Tomas E; Grupo de Estudio de Castilla la Mancha de Enfermedades Infecciosas Group. Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. Clin Infect Dis. 2001;32(3):506-9. [CrossRef]
  • 63. Arapović J, Kompes G, Dedić K, et al. Antimicrobial resistance profiles of human Brucella melitensis isolates in three different microdilution broths: the first multicentre study in Bosnia and Herzegovina. J Glob Antimicrob Resist. 2022;29:99-104. [CrossRef]
  • 64. Parlak M, Güdücüoğlu H, Bayram Y, et al. Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods. Int J Med Sci. 2013;10(10):1406-11. [CrossRef]
  • 65. Tuon FF, Cerchiari N, Cequinel JC, et al; Brucellosis Workgroup. Guidelines for the management of human brucellosis in the State of Paraná, Brazil. Rev Soc Bras Med Trop. 2017;50(4):458-64. [CrossRef]
  • 66. Robichaud S, Libman M, Behr M, Rubin E. Prevention of laboratory-acquired brucellosis. Clin Infect Dis. 2004 Jun 15;38(12):e119-22. [CrossRef]
  • 67. Zervos MJ, Bostic G. Exposure to Brucella in the laboratory. Lancet. 1997;349(9052):651. [CrossRef]
  • 68. Third case of rifampin/penicillin-resistant strain of RB51 brucella from con- suming raw milk, January 24, 2019 [Internet]. Pennsylvania Department of Health. [erişim 16 Mayıs 2022]. https://www.health.pa.gov/topics/Documents/ HAN/2019-PAHAN-434-01-24-19-ADV_RB-51.pdf
  • 69. Centers for Disease Control and Prevention (CDC). Laboratory-acquired brucellosis--Indiana and Minnesota, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(2):39-42.
  • 70. Andriopoulos P, Kalogerakou A, Rebelou D, et al. Prevalence of Brucella antibodies on a previously acute brucellosis infected population: sensitivity, specificity and predictive values of Rose Bengal and Wright standard tube agglutination tests. Infection. 2015;43(3):325-30. [CrossRef]
  • 71. Ciftçi C, Ozoğ F, Oztekin A, et al. [Comparison of the serological tests used for the laboratory diagnosis of brucellosis]. Mikrobiyol Bul. 2005;39(3):291- 9. Turkish.
  • 72. Díaz R, Casanova A, Ariza J, Moriyón I. The Rose Bengal Test in human bru- cellosis: a neglected test for the diagnosis of a neglected disease. PLoS Negl Trop Dis. 2011;5(4):e950. [CrossRef]
  • 73. Mert A, Ozaras R, Tabak F, et al. The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis. 2003;46(4):241-3. [CrossRef]
  • 74. Purwar S, Metgud SC, Mutnal MB, Nagamoti MB, Patil CS. Utility of serological tests in the era of molecular testing for diagnosis of human brucellosis in endemic area with limited resources. J Clin Diagn Res. 2016;10(2):DC26-9. [CrossRef]
  • 75. Sirmatel F, Türker M, Bozkurt AI. [Evaluation of the methods used for the serologic diagnosis of brucellosis]. Mikrobiyol Bul. 2002;36(2):161-7. Turkish.
  • 76. Vrioni G, Gartzonika C, Kostoula A, Boboyianni C, Papadopoulou C, Levid- iotou S. Application of a polymerase chain reaction enzyme immunoassay in peripheral whole blood and serum specimens for diagnosis of acute human brucellosis. Eur J Clin Microbiol Infect Dis. 2004;23(3):194-9. [CrossRef]
  • 77. El-Hossain Aly Reda S, Abd El-Messiah MA, Madkour LA, Kassem AEM. Serology versus real time PCR in the diagnosis of human brucellosis. J Pure Appl Microbio. 2017;11(2):677-83. [CrossRef]
  • 78. Arabacı F, Oldacay M. Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. J Microbiol Infect Dis. 2012;2(2):50-6. [CrossRef]
  • 79. Çeken S, Kaygusuz S, Kılıç D, Ağalar C. [Diagnosis of acute brucellosis by polymerase chain reaction technique]. Turk Hij Den Biyol Derg. 2015;72(2):91- 8. Turkish. [CrossRef]
  • 80. Ertek M, Yazgı, H, Özkurt Z, Ayyildiz A, Parlak M. Comparison of the diagnostic value of the standard tube agglutination test and the ELISA IgG and IgM in patients with brucellosis. Turk J Med Sci. 2006;36(3):159-63.
  • 81. Memish ZA, Almuneef M, Mah MW, Qassem LA, Osoba AO. Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia. Diagn Microbiol Infect Dis. 2002;44(2):129- 32. [CrossRef]
  • 82. Asaad AM, Alqahtani JM. Serological and molecular diagnosis of human brucellosis in Najran, Southwestern Saudi Arabia. J Infect Public Health. 2012;5(2):189-94. [CrossRef]
  • 83. Álvarez-Ojeda MG, Saldaña-Fuentes C, Ballesteros-Elizondo MR, et al. [Com- parison of the tests polymerase chain reaction, serology, and blood culture with respect to sensitivity and specificity for detection of Brucella spp. in human samples]. Gac Med Mex. 2015;151(5):620-7. Spanish.
  • 84. Khodabakhshi B, Abbasi A, Torabi Rostami M, Joshaghani H R, Roshandel G. Comparison of quantitative real-time polymerase chain reaction (qRT-PCR) and agglutination assays in diagnosis of brucellosis in Golestan Province, North of Iran. JoMMID. 2019;7(4):116-9.
  • 85. Kuila P, Dutta D, Chakrabarty U, Chatterjee D, Das S. Comparison of serological tests and PCR for diagnosis of human brucellosis suffering from fever. Asian J Pharm Clin Res. 2017;10(5):109-11. [CrossRef]
  • 86. Morata P, Queipo-Ortuño MI, Reguera JM, García-Ordoñez MA, Cárdenas A, Colmenero JD. Development and evaluation of a PCR-enzyme-linked immunosorbent assay for diagnosis of human brucellosis. J Clin Microbiol. 2003;41(1):144-8. [CrossRef]
  • 87. Surucuoglu S, El S, Ural S, et al. Evaluation of real-time PCR method for rapid diagnosis of brucellosis with different clinical manifestations. Pol J Microbiol. 2009;58(1):15-9.
  • 88. Mitka S, Anetakis C, Souliou E, Diza E, Kansouzidou A. Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods. J Clin Microbiol. 2007;45(4):1211-8. [CrossRef]
  • 89. Ranjbar M, Rezaiee AA, Hashemi SH, Mehdipour S. Neurobrucellosis: report of a rare disease in 20 Iranian patients referred to a tertiary hospital. East Mediterr Health J. 2009;15(1):143-8.
  • 90. McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis. 1992;15(4):582-90. [CrossRef]
  • 91. Patra S, Kalwaje Eshwara V, Pai AR, Varma M, Mukhopadhyay C. Evaluation of clinical, diagnostic features and therapeutic outcome of neurobrucellosis: a case series and review of literature. Int J Neurosci. 2022;132(11):1080-90. [CrossRef]
  • 92. Oueslati I, Berriche A, Ammari L, et al. Epidemiological and clinical char- acteristics of neurobrucellosis case patients in Tunisia. Med Mal Infect. 2016;46(3):123-30. [CrossRef]
  • 93. Dar W, Wani M, Mir F, et al. Isolated neurobrucellosis-characteristic clinical and laboratory features. Acta Neurol Belg. 2022;122(6):1469-75. [CrossRef]
  • 94. Karaoglan I, Namiduru M, Akcali A, Cansel N. Different manifestations of nervous system involvement by neurobrucellosis. Neurosciences (Riyadh). 2008;13(3):283-7.
  • 95. Daif AK. The value of oligoclonal bands in neurobrucellosis. Ann Saudi Med. 1991;11(4):411-3. [CrossRef]
  • 96. Fan S, Ren H, Wei Y, et al. Next-generation sequencing of the cerebrospinal fluid in the diagnosis of neurobrucellosis. Int J Infect Dis. 2018;67:20-4. [CrossRef]
  • 97. Wen H, Jin D, Cai L, Wu T, Liu H. Neurobrucellosis with ischemic stroke and spinal cord involvement: a case report. BMC Neurol. 2021;21(1):129. [CrossRef]
  • 98. Du Y, Yang H, Jiang H, Du X. A Death Due to Neurobrucellosis - Linfen City, Shanxi Province, China, May 2021. China CDC Wkly. 2021;3(53):1144-5. [CrossRef]
  • 99. Yaşar K, Şengöz G, Yıldırım F, Nazlıcan Ö. [Evaluation of cases with neuro- brucellosis]. Bakırköy Tıp Dergisi. 2007;3:57-60. Turkish.
  • 100. Demirdağ K, Özden M, Kalkan M, Çelik İ, Kılıç SS. [Brucellosis: Retrospective evaluation of 146 cases]. Flora. 2002;7(2):120-5. Turkish.
  • 101. Turkoglu SA, Halicioglu S, Sirmatel F, Yildiz M, Yildiz N, Yildiz S. Vasculitis and neurobrucellosis: Evaluation of nine cases using radiologic findings. Brain Behav. 2018;8(4):e00947. [CrossRef]
  • 102. Rossi M, Tascini C, Carannante N, Di Caprio G, Sofia S, Iacobello C. Neu- robrucellosis: diagnostic and clinical management of an atypical case. New Microbiol. 2018;41(2):165-7.
  • 103. Raina S, Sharma A, Sharma R, Bhardwaj A. Neurobrucellosis: A case report from Himachal Pradesh, India, and review of the literature. Case Rep Infect Dis. 2016;2016:2019535. [CrossRef]
  • 104. Eren S, Bayam G, Ergönül O, et al. Cognitive and emotional changes in neurobrucellosis. J Infect. 2006;53(3):184-9. [CrossRef]
  • 105. Sanchez-Sousa A, Torres C, Campello MG, et al. Serological diagnosis of neurobrucellosis. J Clin Pathol. 1990;43(1):79-81. [CrossRef]
  • 106. Ata F, Yousaf Z, Sharif MK, Abdallah A. Demyelinating steroid-responsive neurobrucellosis. BMJ Case Rep. 2020;13(3):e233798. [CrossRef]
  • 107. Obiako OR, Ogoina D, Danbauchi SS, Kwaifa SI, Chom ND, Nwokorie E. Neurobrucellosis--a case report and review of literature. Niger J Clin Pract. 2010;13(3):347-50.
  • 108. Ben Ali N, Mrabet-Khiari H, Echebbi S, Mrabet A. [Neurobrucellosis]. Tunis Med. 2011;89(11):866-7. French.
  • 109. Vafaeimanesh J, Shahamzeh A, Bagherzadeh M. Neurobrucellosis in systemic lupus erythematosus. Caspian J Intern Med. 2017;8(2):119-22. [CrossRef]
  • 110. Despotopoulos S, Akinosoglou K, Tzimas T, Akritidis N, Gogos C. Diagnosis of neurobrucellosis in resource-limited real-world settings: A case-series of 8 patients. J Neurol Sci. 2017;379:293-5. [CrossRef]
  • 111. Mahdavi FS, Abbasi Khoshsirat N, Madanipour A. Lumbosacral polyradiculitis associated with brucellosis. IDCases. 2020;23:e01028. [CrossRef]
  • 112. Al-Sous MW, Bohlega S, Al-Kawi MZ, Alwatban J, McLean DR. Neurobru- cellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol. 2004;25(3):395-401.
  • 113. Yamout BI, Massouh J, Hushaymi I, Zeineddine M, Saab G. Neurobrucellosis presenting as longitudinally extensive transverse myelitis: A case report and review of the literature. Mult Scler Relat Disord. 2020;40:101947. [CrossRef]
  • 114. Kanjo MA, Ahmed HM, Alnahari EA. Unusual presentation of neuro- brucellosis in Jeddah, Kingdom of Saudi Arabia. Neurosciences (Riyadh). 2021;26(4):385-8. [CrossRef]
  • 115. Kemec Z, Tüzün C, Yıldırım İ. Neurobrucellosis presented by cerebral salt wasting. Cureus. 2020;12(5):e8275. [CrossRef]
  • 116. Inan AS, Ceran N, Erdem I, et al. Neurobrucellosis with transient ischemic attack, vasculopathic changes, intracerebral granulomas and basal ganglia infarction: a case report. J Med Case Rep. 2010;4:340. [CrossRef]
  • 117. Colmenero JD, Queipo-Ortuño MI, Reguera JM, Baeza G, Salazar JA, Morata P. Real time polymerase chain reaction: a new powerful tool for the diagno- sis of neurobrucellosis. J Neurol Neurosurg Psychiatry. 2005;76(7):1025-7. [CrossRef]
  • 118. Bajin MD, Savaş Ö, Aslan F, Sennaroğlu L. Cochlear implantation in neuro- brucellosis. Balkan Med J. 2016;33(1):108-11. [CrossRef]
  • 119. Mergen B, Sarici AM, Baltu F, Ozaras R, Adaletli I. An unusual presentation of sixth nerve palsy: neurobrucellosis. GMS Ophthalmol Cases. 2019;9:Doc13. [CrossRef]
  • 120. Ge Y, Guan HZ, Fan SY, Zhu R, Ma XJ, Li TS. [A clinical analysis of 20 pa- tients with neurobrucellosis]. Zhonghua Nei Ke Za Zhi. 2017;56(10):729-33. Chinese. [CrossRef]
  • 121. Khademi A, Poursadeghfard M, Nikandish Noubar R. Neurobrucellosis presented with a hyperacute onset: A case report. Iran J Public Health. 2016;45(12):1652-5.
  • 122. Lulu AR, Araj GF, Khateeb MI, Mustafa MY, Yusuf AR, Fenech FF. Human bru- cellosis in Kuwait: a prospective study of 400 cases. Q J Med. 1988;66(249):39-54.
  • 123. Díaz-Vintimilla JJ, Rosales Hernández LA, Zapata-Arenas R, Sánchez-Montes S, Becker I. Subacute transverse myelitis as a clinical presentation of neuro- brucellosis. J Infect Dev Ctries. 2021;15(9):1359-63. [CrossRef]
  • 124. Akdeniz H, Irmak H, Anlar O, Demiröz AP. Central nervous system brucellosis: presentation, diagnosis and treatment. J Infect. 1998;36(3):297-301. [CrossRef]
  • 125. Mahajan SK, Sharma A, Kaushik M, Raina R, Sharma S, Banyal V. Neuro- brucellosis: an often forgotten cause of chronic meningitis. Trop Doct. 2016 Jan;46(1):54-6. [CrossRef]
  • 126. Shah IA, Kawoos Y, Sanai BA, Rabyang S, Banday D. Neurobrucellosis pre- senting as acute psychosis. J Neurosci Rural Pract. 2018;9(4):644-6. [CrossRef]
  • 127. Akcay Hİ, Kurtuncu M, Celik SY, Gunduz T, Eraksoy M. Neurobrucellosis presenting with mania. Acta Neurol Belg. 2017;117(1):373-5. [CrossRef]
  • 128. Bellissima P, Turturici MA. [Neurobrucellosis: clinical and therapeutic fea- tures]. Infez Med. 1998;6(1):25-30. Italian.
  • 129. Yazdi NA, Moosavi NS, Alesaeidi S, Salahshour F, Ghaemi O. Diffuse neuro- brucellosis of cerebellum, brainstem, spinal cord, and cauda equina: A case report and literature review. J Radiol Case Rep. 2022;16(5):1-9. [CrossRef]
  • 130. Dreshaj S, Shala N, Dreshaj G, Ramadani N, Ponosheci A. Clinical man- ifestations in 82 neurobrucellosis patients from Kosovo. Mater Sociomed. 2016;28(6):408-11.
  • 131. Spyrou A, Natsis KS, Papamichalis E, Mourtzinos H. Intraventricular hae- morrhage and seizures in a patient with dementia: a case of chronic neuro- brucellosis. Age Ageing. 2019;48(4):601-2. [CrossRef]
  • 132. Farhan N, Khan EA, Ahmad A, Ahmed KS. Neurobrucellosis: A report of two cases. J Pak Med Assoc. 2017;67(11):1762-3.
  • 133. Tekin-Koruk S, Duygu F, Gursoy B, Karaagac L, Bayraktar M. A rare case of seronegative neurobrucellosis. Ann Saudi Med. 2010;30(5):412-4. [CrossRef]
  • 134. Li Q, Dai F, Zhu L, Wang J, Jing Y. [Ocular syndromes in patients with neurobrucellosis]. Zhonghua Yan Ke Za Zhi. 2015;51(12):896-900. Chinese.
  • 135. Asadipooya K, Dehghanian A, Omrani GH, Abbasi F. Short-course treatment in neurobrucellosis: a study in Iran. Neurol India. 2011;59(1):101-3. [CrossRef]
  • 136. Awada A, Korri H, Issa Z, Ali Y, Beaini M. [Progressive paraparesis with sensorineural deafness and leukoencephalopathy revealing neurobrucellosis]. Rev Neurol (Paris). 2011;167(2):181-4. French. [CrossRef]
  • 137. Kesav P, Modi M, Singla V, Khurana D, Prabhakar S. Kaleidoscopic presen- tation of neurobrucellosis. J Neurol Sci. 2013;331(1-2):165-7. [CrossRef]
  • 138. Yetkin MA, Bulut C, Erdinc FS, Oral B, Tulek N. Evaluation of the clinical presentations in neurobrucellosis. Int J Infect Dis. 2006;10(6):446-52. [CrossRef]
  • 139. Wu M, Cui R, Li F, Huo L, Luo Y. Extensive intraspinal hypermetabolism caused by neurobrucellosis shown on 18F-FDG PET/CT. Clin Nucl Med. 2020;45(9):722-4. [CrossRef]
  • 140. Goktepe AS, Alaca R, Mohur H, Coskun U. Neurobrucellosis and a demon- stration of its involvement in spinal roots via magnetic resonance imaging. Spinal Cord. 2003;41(10):574-6. [CrossRef]
  • 141. Sarmiento Clemente A, Amerson-Brown MH, Foster CE. An adolescent with neurobrucellosis caused by brucella abortus cattle vaccine strain RB51. Pediatr Infect Dis J. 2021;40(9):e353-5. [CrossRef]
  • 142. Banerjee TK, Pal AK, Das S. Neurobrucellosis presenting as acute meningo- encephalitis. Neurol India. 1999;47(2):160.
  • 143. Kochar DK, Kumawat BL, Agarwal N, et al. Meningoencephalitis in brucellosis. Neurol India. 2000;48(2):170-3.
  • 144. Marques IB, Marto N, Raimundo A, Gil-Gouveia R. Myelitis and polyra- diculoneuropathy with severe pain: Unusual neurological manifestations as presenting symptoms of brucellosis. Neurologist. 2018;23(4):131-4. [CrossRef ]
  • 145. Krishnan C, Kaplin AI, Graber JS, Darman JS, Kerr DA. Recurrent transverse myelitis following neurobrucellosis: immunologic features and beneficial response to immunosuppression. J Neurovirol. 2005;11(2):225-31. [CrossRef]
  • 146. Nashi S, Preethish-Kumar V, Maji S, et al. Case report: Neurobrucellosis with plastered spinal arachnoiditis: A magnetic resonance imaging-based report. Am J Trop Med Hyg. 2018;98(3):800-2. [CrossRef]
  • 147. Ozkavukcu E, Tuncay Z, Selçuk F, Erden I. An unusual case of neurobrucellosis presenting with unilateral abducens nerve palsy: clinical and MRI findings. Diagn Interv Radiol. 2009;15(4):236-8. [CrossRef]
  • 148. Gloeb DJ, Lupi C, O’Sullivan MJ. Neurobrucellosis complicating pregnancy: a case report. Infect Dis Obstet Gynecol. 1994;1(6):285-9. [CrossRef]
  • 149. Udugama JMM, Lekamwasam JDVC, Piyasiri DLB, Wijeweera KDDS, Vi- jayabandara MSK, Wickramasinge DSA. Neurobrucellosis complicated with lumbar epidural abscess; A shepherd’s agony. Ceylon Med J. 2018;63(4):190-1. [CrossRef]
  • 150. Kyebambe PS. Acute brucella meningomyeloencephalo-spondylosis in a teenage male. Afr Health Sci. 2005;5(1):69-72.
  • 151. Gul HC, Erdem H, Gorenek L, et al. Management of neurobrucellosis: an assessment of 11 cases. Intern Med. 2008;47(11):995-1001. [CrossRef]
  • 152. Molins A, Montalbán J, Codina A. Parkinsonism in neurobrucellosis. J Neurol Neurosurg Psychiatry. 1987;50(12):1707-8. [CrossRef]
  • 153. Dias SP, Sequeira J, Almeida M. Spastic paraparesis and sensorineural hearing loss: keep brucellosis in mind. J Neurol Sci. 2018 Feb 15;385:144-5. [CrossRef]
  • 154. Sturniolo G, Mondello P, Bruno S, et al. Neurobrucellosis associated with syndrome of inappropriate antidiuretic hormone with resultant diabetes in- sipidus and hypothyroidism. J Clin Microbiol. 2010;48(10):3806-9. [CrossRef]
  • 155. Rajan R, Khurana D, Kesav P. Deep gray matter involvement in neurobru- cellosis. Neurology. 2013;80(3):e28-9. [CrossRef]
  • 156. Trifiletti RR, Restivo DA, Pavone P, Giuffrida S, Parano E. Diabetes insipidus in neurobrucellosis. Clin Neurol Neurosurg. 2000;102(3):163-5. [CrossRef]
  • 157. Guney F, Gumus H, Ogmegul A, et al. First case report of neurobrucellosis associated with hydrocephalus. Clin Neurol Neurosurg. 2008;110(7):739-42. [CrossRef]
  • 158. Montazeri M, Sadeghi K, Khalili H, Davoudi S. Fever and psychosis as an early presentation of Brucella-associated meningoencephalitis: a case report. Med Princ Pract. 2013;22(5):506-9. [CrossRef]
  • 159. Yousif B, Nelson J. Neurobrucellosis--a rare complication of renal transplan- tation. Am J Nephrol. 2001;21(1):66-8. [CrossRef]
  • 160. Karaoglan I, Akcali A, Ozkur A, Namýdurua M. Neurobrucellosis mimicking demyelinizating disorders. Ann Saudi Med. 2008;28(2):148-9. [CrossRef]
  • 161. Suárez-Esquivel M, Ruiz-Villalobos N, Jiménez-Rojas C, et al. Brucella neoto- mae Infection in Humans, Costa Rica. Emerg Infect Dis. 2017;23(6):997-1000. Erratum in: Emerg Infect Dis. 2017;23(8):1435. [CrossRef]
  • 162. Hatipoglu CA, Yetkin A, Ertem GT, Tulek N. Unusual clinical presentations of brucellosis. Scand J Infect Dis. 2004;36(9):694-7. [CrossRef]
  • 163. Nas K, Tasdemir N, Cakmak E, Kemaloglu MS, Bukte Y, Geyik MF. Cervical intramedullary granuloma of Brucella: a case report and review of the liter- ature. Eur Spine J. 2007;16 Suppl 3(Suppl 3):255-9. Erratum in: Eur Spine J. 2007;16 Suppl 3:260. [CrossRef]
  • 164. Munckhof WJ, Jennison AV, Bates JR, Gassiep I. First report of probable neurobrucellosis in Australia. Med J Aust. 2013;199(6):423-5. [CrossRef]
  • 165. Baldi PC, Araj GF, Racaro GC, Wallach JC, Fossati CA. Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis. Clin Diagn Lab Immunol. 1999;6(5):756-9. [CrossRef]
  • 166. Tugcu B, Nacaroglu SA, Coskun C, Kuscu DY, Onder F. Chronic Meningitis Complicating Intracranial Hypertension in Neurobrucellosis: A Case Report. Semin Ophthalmol. 2015;30(5-6):429-31. [CrossRef]
  • 167. Van den Enden E, Vlieghe E, Demeester R, Ieven G, Jansens H, Van den Hauwe L. A traveler with neurobrucellosis. Travel Med Infect Dis. 2009;7(4):215-8. [CrossRef]
  • 168. Kizilkilic O, Turunc T, Yildirim T, Demiroglu YZ, Hurcan C, Uncu H. Suc- cessful medical treatment of intracranial abscess caused by Brucella spp. J Infect. 2005;51(1):77-80. [CrossRef]
  • 169. Kochar DK, Gupta BK, Gupta A, Kalla A, Nayak KC, Purohit SK. Hospi- tal-based case series of 175 cases of serologically confirmed brucellosis in Bikaner. J Assoc Physicians India. 2007;55:271-5.
  • 170. Alqwaifly M, Al-Ajlan FS, Al-Hindi H, Al Semari A. Central nervous system brucellosis granuloma and white matter disease in immunocompromised patient. Emerg Infect Dis. 2017;23(6):978-81. [CrossRef]
  • 171. Bingöl A, Togay-Işikay C. Neurobrucellosis as an exceptional cause of transient ischemic attacks. Eur J Neurol. 2006;13(5):544-8. [CrossRef]
  • 172. Kesav P, Vishnu VY, Khurana D. Fatal disseminated neurobrucellosis. QJM. 2014;107(4):321-2. [CrossRef]
  • 173. Karaca S, Demiroglu YZ, Karataş M, Tan M. Acquired progressive spas- tic paraparesis due to neurobrucellosis: a case report. Acta Neurol Belg. 2007;107(4):118-21.
  • 174. Adaletli I, Albayram S, Gurses B, et al. Vasculopathic changes in the cerebral arterial system with neurobrucellosis. AJNR Am J Neuroradiol. 2006;27(2):384-6.
  • 175. Ozisik HI, Ersoy Y, Refik Tevfik M, Kizkin S, Ozcan C. Isolated intracranial hypertension: a rare presentation of neurobrucellosis. Microbes Infect. 2004 Jul;6(9):861-3. [CrossRef]
  • 176. Sengoz G, Yasar KK, Yildirim F, Nazlican O. Sensorineural hearing loss in neurobrucellosis. Neurosciences (Riyadh). 2008;13(3):299-301.
  • 177. Erdem M, Namiduru M, Karaoglan I, Kecik VB, Aydin A, Tanriverdi M. Unusual presentation of neurobrucellosis: a solitary intracranial mass lesion mimicking a cerebral tumor : a case of encephalitis caused by Brucella meli- tensis. J Infect Chemother. 2012;18(5):767-70. [CrossRef]
  • 178. Ay S, Tur BS, Kutlay S. Cerebral infarct due to meningovascular neurobru- cellosis: a case report. Int J Infect Dis. 2010;14 Suppl 3:e202-4. [CrossRef]
  • 179. Ciftçi E, Erden I, Akyar S. Brucellosis of the pituitary region: MRI. Neurora- diology. 1998;40(6):383-4. [CrossRef]
  • 180. Solaroglu I, Kaptanoglu E, Okutan O, Beskonakli E. Solitary extra-axial pos- terior fossa abscess due to neurobrucellosis. J Clin Neurosci. 2003;10(6):710-2. [CrossRef]
  • 181. Bilen S, Güneş HN, Saka M, Ak F. Four different clinical manifestations of neurobrucellosis (case reports). Eur J Intern Med. 2008;19(8):e75-7. [CrossRef]
  • 182. Yilmaz M, Ozaras R, Mert A, Ozturk R, Tabak F. Abducent nerve palsy during treatment of brucellosis. Clin Neurol Neurosurg. 2003;105(3):218-20. [CrossRef]
  • 183. Roig J, Sarró F, Borrás M, Fernández E. [Intracranial hypertension as presentation of neurobrucellosis in a patient on hemodialysis]. Nefrologia. 2008;28(5):568-9. Spanish.
  • 184. Koussa S, Chemaly R. Neurobrucellosis presenting with diffuse cerebral white matter lesions. Eur Neurol. 2003;50(2):121-3. [CrossRef]
  • 185. Ulas UH, Hamamcioglu K, Eroglu E, et al. Paraplegia associated with bru- cellosis involving the anterior lumbrosacral nerve roots. J Peripher Nerv Syst. 2003;8(1):8-12. [CrossRef]
  • 186. Novati R, Viganò MG, de Bona A, Nocita B, Finazzi R, Lazzarin A. Neuro- brucellosis with spinal cord abscess of the dorsal tract: a case report. Int J Infect Dis. 2002;6(2):149-50. [CrossRef]
  • 187. Tuncer-Ertem G, Tülek N, Yetkin MA. [Case report: subdural hemorrhage in neurobrucellosis]. Mikrobiyol Bul. 2004;38(3):253-6. Turkish.
  • 188. Zaidan R, Al Tahan AR. Cerebral venous thrombosis: a new manifestation of neurobrucellosis. Clin Infect Dis. 1999;28(2):399-400. [CrossRef]
  • 189. Oliveri Rl, Matera G, Focà A, Zappia M, Aguglia U, Quattrone A. Polyradicu- loneuropathy with cerebrospinal fluid albuminocytological dissociation due to neurobrucellosis. Clin Infect Dis. 1996;23(4):833-4. [CrossRef]
  • 190. da Cunha S, Gaspar E, Meliço-Silvestre A, Azlvedo-Bernarda R, da Costa C. Neurobrucellosis--another cause of increased adenosine deaminase activity in cerebrospinal fluid. J Infect Dis. 1990;161(1):156-7. [CrossRef]
  • 191. Kutlu M, Cevahir N, Erdenliğ-Gürbilek S, Akalın Ş, Uçar M, Sayın-Kutlu S. The first report of Brucella suis biovar 1 isolation in human in Turkey. J Infect Public Health. 2016;9(5):675-8. [CrossRef]
  • 192. Güleç F, Uysal HS, Y, Zorlu Y. Lökoensefalopati ve sağırlık ile başvuran Bir nörobruselloz olgusu. Turk Norol Derg. 2011;17:102-5.
  • 193. Ertem G, Kutlu G, Ataman Hatipoğlu Ç, Bulut C, Demiröz AP. A rare pre- sentation of brucellosis: polyradiculopathy and peripheral neuritis. Turkish Journal of Medical Sciences. 2012;42(2):359-64. [CrossRef]
  • 194. Kaya S, Kostakoğlu U. [A brucellosis case with macular rash and peripheral neuropathy]. Mikrobiyol Bul. 2009;43(1):147-51. Turkish.
  • 195. Karaca S, Selçuki D, Mavioğlu H, Dönmez H. [Neurobrucellosis]. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2001;54(4):381-6. Turkish.
  • 196. Ural O, Güler S. [Neurobrucellosis: A case report]. Flora 2007;12(4):208-10. Turkish.
  • 197. Ateş MA, Algül A, Geçici Ö, Semiz UB, Turhan V, Çetin M. [Acute psy- chosis due to neurobrucellosis: A case report]. Anadolu Psikiyatri Dergisi. 2008;9(3):188-90. Turkish.
  • 198. Özdemir D, Albayrak F, Cesur S, Gönenli B, Sözen T, Tekeli E. [A case of neurobrucellosis]. İnfeksiyon Dergisi. 2003;17(4):499-500.
  • 199. Akin A, Demiralin F, Bilgin RR, Tosun S, Mermut G, Gedizlioğlu M. A case of neurobrucellosis. J Exp Clin Med. 2015;32(1):39-41.
  • 200. Papadopoulos VE, Patas K, Tountopoulou A, et al. Seronegative neuro- brucellosis-do we need new neurobrucellosis criteria? Int J Infect Dis. 2021;111:124-6. [CrossRef]
  • 201. Karsen H, Akdeniz H, Karahocagil MK, Irmak H, Sünnetçioğlu M. Toxic-fe- brile neurobrucellosis, clinical findings and outcome of treatment of four cases based on our experience. Scand J Infect Dis. 2007;39(11-12):990-5. [CrossRef]
  • 202. Bains R, Dahhan T, Belzowski A, Heinze ER, Wong AL, Clements PJ. An interesting case of neurobrucellosis mimicking neuropsychiatric lupus. Case Rep Rheumatol. 2018;2018:9793535. [CrossRef]
  • 203. Renard D, Taieb G, Heroum C, Lado S. Meningomyeloradiculitis as presenting feature of brucellosis. J Neurol. 2006;253(12):1651-2. [CrossRef]
  • 204. Mousa AR, Koshy TS, Araj GF, et al. Brucella meningitis: presentation, diagnosis and treatment--a prospective study of ten cases. Q J Med. 1986;60(233):873-85.
  • 205. Araj GF, Lulu AR, Khateeb MI, Saadah MA, Shakir RA. ELISA versus routine tests in the diagnosis of patients with systemic and neurobrucellosis. APMIS. 1988;96(2):171-6.
  • 206. Araj GF, Lulu AR, Saadah MA, Mousa AM, Strannegard IL, Shakir RA. Rapid diagnosis of central nervous system brucellosis by ELISA. J Neuroimmunol. 1986;12(3):173-82. [CrossRef]
  • 207. Li Q, Liu J, Jiang W, et al. A case of brucellosis-induced Guillain-Barre syn- drome. BMC Infect Dis. 2022;22(1):72. [CrossRef]
  • 208. Ahmed R, Patil BS. Neurobrucellosis: a rare cause for spastic paraparesis. Braz J Infect Dis. 2009;13(3):245. [CrossRef]
  • 209. Vinod P, Singh MK, Garg RK, Agarwal A. Extensive meningoencephalitis, retrobulbar neuritis and pulmonary involvement in a patient of neurobru- cellosis. Neurol India. 2007;55(2):157-9. [CrossRef]
  • 210. Kumral E, Çetin FE. Variants of avellis syndrome due to medulla oblongata infarction: a case series. neurologist. 2021;26(5):185-8. [CrossRef]
  • 211. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the prevention, diagnosis and treatment of lyme disease. Clin Infect Dis. 2021;72(1):e1-e48. [CrossRef]
  • 212. Solera J, Geijo P, Largo J, et al; Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis. Clin Infect Dis. 2004;39(12):1776-82. [CrossRef]
  • 213. Colmenero Castillo JD, Hernandez Marquez S, Reguera Iglesias JM, Cabrera Franquelo F, Rius Diaz F, Alonso A. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis. Chemotherapy. 1989;35(2):146-52. [CrossRef]
  • 214. Agalar C, Usubutun S, Turkyilmaz R. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis. Eur J Clin Microbiol Infect Dis. 1999;18(8):535-8. [CrossRef]
  • 215. Karabay O, Sencan I, Kayas D, Sahin I. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]. BMC Infect Dis. 2004;4:18. [CrossRef]
  • 216. Montejo JM, Alberola I, Glez-Zarate P, et al. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis. 1993;16(5):671-6. [CrossRef]
  • 217. Majzoobi MM, Hashmi SH, Emami K, Soltanian AR. Combination of doxycycline, streptomycin and hydroxychloroquine for short-course treatment of brucellosis: a single-blind randomized clinical trial. Infection. 2022;50(5):1267-71. [CrossRef]
  • 218. Acocella G, Bertrand A, Beytout J, et al. Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. J Antimicrob Chemother. 1989;23(3):433-9. Erratum in: J Antimicrob Chemother. 1989;24(4):629. [CrossRef]
  • 219. Ariza J, Gudiol F, Pallares R, et al. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med. 1992;117(1):25-30. [CrossRef]
  • 220. Colmenero JD, Fernández-Gallardo LC, Agúndez JA, Sedeño J, Benítez J, Valverde E. Possible implications of doxycycline-rifampin interaction for treatment of brucellosis. Antimicrob Agents Chemother. 1994;38(12):2798- 802. [CrossRef]
  • 221. Ersoy Y, Sonmez E, Tevfik MR, But AD. Comparison of three different combination therapies in the treatment of human brucellosis. Trop Doct. 2005;35(4):210-2. Erratum in: Trop Doct. 2006;36(2):128. [CrossRef]
  • 222. Hashemi SH, Gachkar L, Keramat F, et al. Comparison of doxycycline-strep- tomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Int J Infect Dis. 2012;16(4):e247-51. [CrossRef]
  • 223. Ariza J, Gudiol F, Pallarés R, Rufí G, Fernández-Viladrich P. Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis. J Infect Dis. 1985;152(6):1358-9. [CrossRef]
  • 224. Solera J, Rodríguez-Zapata M, Geijo P, et al. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Antimicrob Agents Chemother. 1995;39(9):2061- 7. [CrossRef]
  • 225. Roushan MR, Mohraz M, Hajiahmadi M, Ramzani A, Valayati AA. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis. 2006;42(8):1075- 80. [CrossRef]
  • 226. Roushan MR, Amiri MJ, Janmohammadi N, Hadad MS, Javanian M, Baiani M, Bijani A. Comparison of the efficacy of gentamicin for 5 days plus dox- ycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial. J Antimicrob Chemother. 2010;65(5):1028-35. [CrossRef]
  • 227. Akova M, Uzun O, Akalin HE, Hayran M, Unal S, Gür D. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycy- cline-rifampin. Antimicrob Agents Chemother. 1993;37(9):1831-4. [CrossRef]
  • 228. Hasanain A, Mahdy R, Mohamed A, Ali M. A randomized, comparative study of dual therapy (doxycycline-rifampin) versus triple therapy (doxycy- cline-rifampin-levofloxacin) for treating acute/subacute brucellosis. Braz J Infect Dis. 2016;20(3):250-4. [CrossRef]
  • 229. Keramat F, Ranjbar M, Mamani M, Hashemi SH, Zeraati F. A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-dox- ycycline and doxycycline-rifampin in the treatment of brucellosis. Trop Doct. 2009;39(4):207-10. [CrossRef]
  • 230. Kalo T, Novi S, Nushi A, Dedja S. Ciprofloxacin plus doxycycline versus rifampicin plus doxycycline in the treatment of acute brucellosis. Med Mal Infect. 1996;26: 587-9.
  • 231. Saltoglu N, Tasova Y, Inal AS, Seki T, Aksu HS. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis. Saudi Med J. 2002;23(8):921-4.
  • 232. Taghvaee MR, Nozadi MS, Hassani M. A comparison between doxycy- cline-rifampin and ciprofloxacin-rifampin regimens in the treatment of acute Brucellosis. Indian J Med Sci. 2011;65(10):436-43.
  • 233. Sarmadian H, Didgar F, Sufian M, Zarinfar N, Salehi F. Comparison between efficacy of ciprofloxacin doxycycline and rifampin doxycycline regimens in treatment and relapse of brucellosis. Tropical Medicine & International Health. 2009;14(suppl 2):209.
  • 234. FDA updates warnings for fluoroquinolone antibiotics [Internet]. New Hampshire: US.S. Food and Drug Administration (FDA). [erişim 12 Ekim 2022]. https://www.fda.gov/news-events/press-announcements/fda-up- dates-warnings-fluoroquinolone-antibiotics
  • 235. Bosilkovski M, Stojovski M, Siskova D, Ridov A, Kostoska E, Krstevski K. Brucellosis in pregnancy: case reports with different outcomes in an endemic region. Acta Clin Croat. 2020;59(2):338-43. [CrossRef]
  • 236. Sayılır K, Kutlu SS, Baykam N, Eren Ş, Çelikbaş AK, Dokuzoğuz B. [Sponta- neous abortion due to Brucellosis: Report of two cases]. İnfeksiyon Dergisi. 2003;17(3):345-8. Turkish.
  • 237. Yapça ÖE, Satılmış ÖK, Yapça D, Gül S. [Brucella seroprevalence among pregnant women in Sorgun district of Yozgat]. KÜ Tıp Fak Derg. 2013;15(1):26- 8. Turkish.
  • 238. Karcaaltincaba D, Sencan I, Kandemir O, Guvendag-Guven ES, Yalvac S. Does brucellosis in human pregnancy increase abortion risk? Presentation of two cases and review of literature. J Obstet Gynaecol Res. 2010;36(2):418-23. [CrossRef]
  • 239. al-Aska AK, Chagla AH. Laboratory-acquired brucellosis. J Hosp Infect. 1989;14(1):69-71. [CrossRef]
  • 240. Roushan MR, Baiani M, Asnafi N, Saedi F. Outcomes of 19 pregnant wom- en with brucellosis in Babol, northern Iran. Trans R Soc Trop Med Hyg. 2011;105(9):540-2. [CrossRef]
  • 241. Jensenius M, von der Lippe B, Hermansen NO, et al. Brucellar mastitis: pre- sentation of a case and review of the literature. Int J Infect Dis. 2008;12(1):98- 100. [CrossRef]
  • 242. Giannacopoulos I, Eliopoulou MI, Ziambaras T, Papanastasiou DA. Trans- placentally transmitted congenital brucellosis due to Brucella abortus. J Infect. 2002;45(3):209-10. [CrossRef]
  • 243. Cebesoy FB, Balat O, Mete A. An extraordinary cause of vertebral fracture in pregnant woman: brucellosis. Arch Gynecol Obstet. 2009;280(2):301-3. [CrossRef]
  • 244. Shamo’on H, Izzat M. Congenital brucellosis. Pediatr Infect Dis J. 1999;18(12):1110- 1. [CrossRef]
  • 245. Ceylan A, Köstü M, Tuncer O, Peker E, Kırımi E. Neonatal brucellosis and breast milk. Indian J Pediatr. 2012;79(3):389-91. [CrossRef]
  • 246. Malone FD, Athanassiou A, Nores LA, Dalton ME. Poor perinatal outcome associated with maternal Brucella abortus infection. Obstet Gynecol. 1997;90(4 Pt 2):674-6. [CrossRef]
  • 247. Inan A, Erdem H, Elaldi N, et al. Brucellosis in pregnancy: results of multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis. 2019;38(7):1261-8. [CrossRef]
  • 248. Akçam FZ, Akçam M, Yılmaz M, Temel EN, Kaya O, Yılmaz GR. [Neurobrucel- losis: Two cases, two different presentations]. Turk J Neurol. 2020;26(4):342-5. Turkish. [CrossRef]
  • 249. Mutlu B, Bolca Z, Kalender B, Gündeş S, Vahaboğlu H. [A case of neurobru- cellosis with depressive symptoms and treatment intoolerance]. İnfeksiyon Dergisi. 2002;16(1):99-101. Turkish.
  • 250. Türkoğlu R, Gencer M, Çetinkaya Y, Tireli H. [Neurobrucellosis mimick- ing multiple sclerosis: Report of two cases]. Archieves of Neuropsychiatry. 2007;44:120-3. Turkish.
  • 251. Kalkan A, Bulut V, Bulut S, Berilgen MS, Müngen B. [Neurobrucellosis: Case report]. İnfeksiyon Dergisi. 2000;14(1):131-4. Turkish.
  • 252. Ataman-Hatipoğlu Ç, Yetkin A, Tuncer-Ertem G, Tanyel E, Oral B, Tülek N. [Unusual clinical presentations of brucellosis]. İnfeksiyon Dergisi. 2005;19(1):47-52. Turkish.
  • 253. Kayaaslan B, Akıncı E, Baştuğ A, et al. Analysis of 161 adult patients with brucellosis. Turk J Med Sci. 2013;43:187-93. [CrossRef]
  • 254. Powers HR, Nelson JR, Alvarez S, Mendez JC. Neurobrucellosis associated with feral swine hunting in the southern United States. BMJ Case Rep. 2020;13(12):e238216. [CrossRef]
  • 255. Thomas R, Kameswaran M, Murugan V, Okafor BC. Sensorineural hearing loss in neurobrucellosis. J Laryngol Otol. 1993;107(11):1034-6. [CrossRef]
  • 256. Miyares FR, Deleu D, ElShafie SS, et al. Irreversible papillitis and ophthal- moparesis as a presenting manifestation of neurobrucellosis. Clin Neurol Neurosurg. 2007;109(5):439-41. [CrossRef]
  • 257. Islam MN. An elderly lady with neurobrucellosis and multiple co-morbid conditions. Mymensingh Med J. 2018;27(2):412-6.
  • 258. Fatani DF, Alsanoosi WA, Badawi MA, Thabit AK. Ceftriaxone use in bru- cellosis: A case series. IDCases. 2019;18:e00633. [CrossRef]
  • 259. Abduljabbar M. Efficacy of antibiotics in neurobrucellosis. Eur J Neurol. 1995;2(2):123-6. [CrossRef]
  • 260. Lemnouer A, Frikh M, Maleb A, Ahizoune A, Bourazza A, Elouennass M. Bru- cellosis: A cause of meningitis not to neglect. IDCases. 2017;10:97-99. [CrossRef]
  • 261. Vajramani GV, Nagmoti MB, Patil CS. Neurobrucellosis presenting as an intra-medullary spinal cord abscess. Ann Clin Microbiol Antimicrob. 2005;4:14. [CrossRef]
  • 262. Bussone G, La Mantia L, Grazzi L, Lamperti E, Salmaggi A, Strada L. Neurobrucellosis mimicking multiple sclerosis: a case report. Eur Neurol. 1989;29(4):238-40. [CrossRef]
  • 263. Bucher A, Gaustad P, Pape E. Chronic neurobrucellosis due to Brucella melitensis. Scand J Infect Dis. 1990;22(2):223-6. [CrossRef]
  • 264. al Kasab S, al Fagih M, al Rasheed A, et al. Management of Brucella endocarditis with aortic root abscess. Chest. 1990;98(6):1532-4. [CrossRef]
  • 265. Pazderka E, Jones JW. Brucella abortus endocarditis: successful treatment of an infected aortic valve. Arch Intern Med. 1982 Aug;142(8):1567-8. [CrossRef]
  • 266. Heibig J, Beall AC Jr, Myers R, Harder E, Feteih N. Brucella aortic endocarditis corrected by prosthetic valve replacement. Am Heart J. 1983;106(3):594-6. [CrossRef]
  • 267. Flugelman MY, Galun E, Ben-Chetrit E, Caraco J, Rubinow A. Brucellosis in patients with heart disease: when should endocarditis be diagnosed? Cardiology. 1990;77(4):313-7. [CrossRef]
  • 268. Randa T, Christelle E, Rachoin R, et al. Brucella involving the heart: a hidden disease. Int J Cardiovasc Imaging. 2021;37(10):2901-4. [CrossRef]
  • 269. Jeroudi MO, Halim MA, Harder EJ, Al-Siba’i MB, Ziady G, Mercer EN. Brucella endocarditis. Br Heart J. 1987;58(3):279-83. [CrossRef]
  • 270. Göz M, Gürsoy B, Hazar A, Demir D, Koçasan A, Söylemez N. Concomitant aortic valve replacement and mitral valve repair: A case of endocarditis of brucella. Göztepe Tıp Dergisi. 2009;24(4):201-3.
  • 271. Akinci E, Gol MK, Balbay Y. A case of prosthetic mitral valve endocarditis caused by Brucella abortus. Scand J Infect Dis. 2001;33(1):71-2. [CrossRef]
  • 272. Hadjinikolaou L, Triposkiadis F, Zairis M, Chlapoutakis E, Spyrou P. Successful management of Brucella mellitensis endocarditis with combined medical and surgical approach. Eur J Cardiothorac Surg. 2001;19(6):806-10. [CrossRef]
  • 273. Chan R, Hardiman RP. Endocarditis caused by Brucella melitensis. Med J Aust. 1993;158(9):631-2. [CrossRef]
  • 274. Guerrero ML, Aldámiz G, Bayón J, Cohen VA, Fraile J. Long-term survival of salvage cardiac transplantation for infective endocarditis. Ann Thorac Surg. 2011 Nov;92(5):e93-4. [CrossRef]
  • 275. Fernández-Guerrero ML, Martinell J, Aguado JM, Ponte MC, Fraile J, de Rábago G. Prosthetic valve endocarditis caused by Brucella mellitensis. A report of four cases successfully treated with tetracycline, streptomycin, and sulfamethoxazole and trimethoprim plus valve replacement. Arch Intern Med. 1987;147(6):1141-3.
  • 276. Alhyari AR, Bakri FG, Al-Mousa EN, Al-Smady MM. Successful treatment of Brucella endocarditis with aortic root abscess. Saudi Med J. 2005;26(3):473-5.
  • 277. Sayar N, Terzi S, Yilmaz HY, et al. A case of prosthetic mitral valve Bru- cella endocarditis complicated with torsades de pointes. Heart Vessels. 2006;21(5):331-3. [CrossRef]
  • 278. Park SH, Choi YS, Choi YJ, Cho SH, Yoon HJ. Brucella endocarditis with splenic abscess: a report of the first case diagnosed in Korea. Yonsei Med J. 2009;50(1):142-6. [CrossRef]
  • 279. Pratt DS, Tenney JH, Bjork CM, Reller LB. Successful treatment of Brucella melitensis endocarditis. Am J Med. 1978;64(5):897-900. [CrossRef]
  • 280. Şimşek-Yavuz S, Şensoy A, Kaşıkçıoğlu H, et al. Infective endocarditis in Turkey: aetiology, clinical features, and analysis of risk factors for mortality in 325 cases. Int J Infect Dis. 2015;30:106-14. [CrossRef]
  • 281. Du N, Wang F. Clinical characteristics and outcome of Brucella endocarditis. Turk J Med Sci. 2016;46(6):1729-33. [CrossRef]
  • 282. Gunes Y, Tuncer M, Guntekin U, et al. Clinical characteristics and outcome of Brucella endocarditis. Trop Doct. 2009;39(2):85-8. [CrossRef]
  • 283. Jia B, Zhang F, Pang P, et al. Brucella endocarditis: Clinical features and treat- ment outcomes of 10 cases from Xinjiang, China. J Infect. 2017;74(5):512-4. [CrossRef]
  • 284. Jariwala P. 3D transthoracic echocardiography of Brucella endoaortitis and endocarditis of the aortic valve and ascending aorta. Echocardiography. 2013;30(7):E215-7. [CrossRef]
  • 285. Sasmazel A, Baysal A, Fedakar A, et al. Treatment of Brucella endocarditis: 15 years of clinical and surgical experience. Ann Thorac Surg. 2010;89(5):1432- 6. [CrossRef]
  • 286. al-Harthi SS. The morbidity and mortality pattern of Brucella endocarditis. Int J Cardiol. 1989;25(3):321-4. [CrossRef]
  • 287. Amirghofran AA, Karimi A, Emaminia A, Sharifkazemi MB, Salaminia S. Brucellosis relapse causing prosthetic valve endocarditis and aortic root infective pseudoaneurysm. Ann Thorac Surg. 2011;92(4):e77-9. [CrossRef]
  • 288. Brigandi’ A, Terranova C, Toscano A, Vita G. Acute ischemic stroke due to endocarditis from Brucella infection. Neurol Sci. 2020;41(4):953-4. [CrossRef]
  • 289. Mert A, Kocak F, Ozaras R, et al. The role of antibiotic treatment alone for the management of Brucella endocarditis in adults: a case report and literature review. Ann Thorac Cardiovasc Surg. 2002;8(6):381-5.
  • 290. Sabzi F, Heidari A, Faraji R. Right ventricular outflow tract endocarditis caused by brucellosis. J Infect Public Health. 2017;10(5):678-80. [CrossRef]
  • 291. Cohen N, Golik A, Alon I, et al. Conservative treatment for Brucella endo- carditis. Clin Cardiol. 1997;20(3):291-4. [CrossRef]
  • 292. Oguzhan N, Akgun H, Unal A, et al. Brucella glomerulonephritis and prosthetic valve endocarditis: a case report. Int Urol Nephrol. 2012;44(2):643-6. [CrossRef]
  • 293. Al Dahouk S, Schneider T, Jansen A, et al. Brucella endocarditis in prosthetic valves. Can J Cardiol. 2006;22(11):971-4. [CrossRef]
  • 294. Acar A, Turhan V, Diktaş H, Oncül O, Cavuşlu S. [A case of brucellosis complicated with endocarditis, pyelonephritis, sacroileitis and thyroiditis]. Mikrobiyol Bul. 2009;43(1):141-5. Turkish.
  • 295. Cay S, Cagirci G, Maden O, Balbay Y, Aydogdu S. Brucella endocarditis - a registry study. Kardiol Pol. 2009;67(3):274-80.
  • 296. Jacobs F, Abramowicz D, Vereerstraeten P, Le Clerc JL, Zech F, Thys JP. Bru- cella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis. 1990;12(5):740-4. [CrossRef]
  • 297. Almér LO. A case of brucellosis complicated by endocarditis and disseminated intravascular coagulation. Acta Med Scand. 1985;217(1):139-40. [CrossRef]
  • 298. Golden B, Layman TE, Koontz FP, Mergner WJ. Brucella suis endocarditis. South Med J. 1970 Apr;63(4):392-5.
  • 299. Yildiz A, Tufekcioglu O, Aras D, Ozeke O, Celenk MK, Sasmaz A. Myocar- dial noncompaction presenting with Brucella endocarditis. Int J Cardiol. 2009;131(3):e87-9. [CrossRef]
  • 300. Raju IT, Solanki R, Patnaik AN, Barik RC, Kumari NR, Gulati AS. Brucella endocarditis - a series of five case reports. Indian Heart J. 2013;65(1):72-7. [CrossRef]
  • 301. al-Kasab S, al-Fagih MR, al-Yousef S, et al. Brucella infective endocarditis. Successful combined medical and surgical therapy. J Thorac Cardiovasc Surg. 1988;95(5):862-7.
  • 302. Dourakis S, Sambatakou H, Tsiachris D, Kittou N, Alexopoulou A, Archiman- dritis A. A 70-year-old stock-breeder with tricuspid valve and defibrillator lead Brucella endocarditis. Int J Cardiol. 2008;126(3):e47-9. [CrossRef]
  • 303. Sunar H, Duran E. Vegetectomy in Brucella endocarditis. Ann Thorac Surg. 2002;73(6):2036. [CrossRef]
  • 304. Özsöyler I, Yılık L, Bozok S, et al. Brucella endocarditis: the importance of surgical timing after medical treatment (five cases). Prog Cardiovasc Dis. 2005;47(4):226-9. [CrossRef]
  • 305. Manade VV, Kakrani A, Gadage SN, Misra R. Brucella endocarditis in a non-endemic area presenting as pyrexia of unknown origin. BMJ Case Rep. 2014;2014:bcr2014203555. [CrossRef]
  • 306. Keleş C, Bozbuğa N, Sişmanoğlu M, et al. Surgical treatment of Brucella endocarditis. Ann Thorac Surg. 2001;71(4):1160-3. [CrossRef]
  • 307. O’Meara JB, Eykyn S, Jenkins BS, Braimbridge MV, Phillips I. Brucella meli- tensis endocarditis: successful treatment of an infected prosthetic mitral valve. Thorax. 1974;29(3):377-81. [CrossRef]
  • 308. Al-Khuwaitir TS, Wani BA, Sherbeeni SM. Combined Brucella melitensis and streptococcal viridans endocarditis. Saudi Med J. 2002;23(1):99-103.
  • 309. Obrenović-Kirćanski B, Velinović M, Vranes M, et al. Mitral valve endocarditis during brucellosis relapse. Vojnosanit Pregl. 2012;69(8):725-9.
  • 310. Yazıcı HU, Mert KU, Senol U, Ulus T. [A case with tricuspid valve Brucella endocarditis presenting with acute right heart failure]. Turk Kardiyol Dern Ars. 2012;40(4):364-7. Turkish. [CrossRef]
  • 311. Köse Ş, Serin Senger S, Ersan G, Oğuz F, Kuzucu L. Presentation of two cases diagnosed with Brucella endocarditis. Intern Med. 2012;51(8):953-5. [CrossRef]
  • 312. Yavuz T, Ozaydin M, Ulusan V, Ocal A, Ibrisim E, Kutsal A. A case of mitral stenosis complicated with seronegative Brucella endocarditis. Jpn Heart J. 2004;45(2):353-8. [CrossRef]
  • 313. Botta L, Bechan R, Yilmaz A, Di Bartolomeo R. Prosthetic valve endocarditis due to Brucella: successful outcome with a combined strategy. J Cardiovasc Med (Hagerstown). 2009;10(3):257-8. [CrossRef]
  • 314. Cakalagaoglu C, Keser N, Alhan C. Brucella-mediated prosthetic valve endocarditis with brachial artery mycotic aneurysm. J Heart Valve Dis. 1999;8(5):586-90.
  • 315. Tuncer M, Ekim H, Güneş Y, Güntekin U. Atrial septal defect presenting with Brucella endocarditis. Circ J. 2008;72(12):2096-7. [CrossRef]
  • 316. Koumallos N, Paschalis A, Antoniades C, et al. Valve replacement for Brucella endocarditis: two case reports. Int J Cardiol. 2008;127(2):e83-5. [CrossRef]
  • 317. Shetty RK, Madken M, Naha K, Vivek G. Successful management of na- tive-valve Brucella endocarditis with medical therapy alone. BMJ Case Rep. 2013;2013:bcr2013200086. [CrossRef]
  • 318. Keshtkar-Jahromi M, Boroumand M, Razavi SM, et al. Brucella endocarditis, a report of 14 cases (1991-2009). J Infect. 2010;61(1):89-92. [CrossRef]
  • 319. Caylan R, Keske S, Durmaz T, Keles T, Tasyaran MA. A case of Brucella endocarditis in association with superficial femoral artery thrombus. Trop Doct. 2009;39(4):251-2. [CrossRef]
  • 320. Alsoub H, El-Shafie SS. A farmer with artificial valve endocarditis. Postgrad Med J. 2001;77(904):126-7. [CrossRef]
  • 321. Abu Romeh SH, Kozma GN, Johny KV, Sabha M. Brucella endocarditis causing acute renal failure. Nephron. 1987;46(4):388-9. [CrossRef]
  • 322. Je HG, Song H. Brucella endocarditis in a non-endemic country: first reported case in East Asia. Circ J. 2008;72(3):500-1. [CrossRef]
  • 323. Biyik I, Oto O, Ergene O. Brucella pancarditis with dissecting aortic root abscess, left ventricular pseudoaneurysm and ventricular septal defect. J Int Med Res. 2007;35(3):422-6. [CrossRef]
  • 324. Schvarcz R, Svedenhag J, Rådegran K. A case of Brucella melitensis endocarditis successfully treated by a combination of surgical resection and antibiotics. Scand J Infect Dis. 1995;27(6):641-2. [CrossRef]
  • 325. Sungur C, Sungur A, Gedikoglu G, et al. Fatal Brucella melitensis endocarditis in a hemodialysis patient. Nephron. 1994;67(2):234-5. [CrossRef]
  • 326. Leandro J, Roberto H, Antunes M. Brucella endocarditis of the aortic valve. Eur J Cardiothorac Surg. 1998;13(1):95-7. [CrossRef]
  • 327. Skillington PD, McGiffin DC, Kemp R, Bett JH, Holt G, Forgan-Smith R. Brucellosis complicated by aortic valve endocarditis. Aust N Z J Med. 1988 Dec;18(7):872-3. [CrossRef]
  • 328. Katircibaşi MT, Koçum HT, Cölkesen AY, Tekin A, Sezgin AT. Management of Brucella endocarditis on native mitral valve in a patient with prosthetic aortic valve: a case report. Int J Cardiol. 2008;129(2):300-1. [CrossRef]
  • 329. Murdaca G, Colombo BM, Caiti M, Cagnati P, Massa G, Puppo F. Remission of Brucella endocarditis in a patient with mitral valve mechanical prosthesis by antibiotic therapy alone: a case report. Int J Cardiol. 2007;117(1):e35-6. [CrossRef]
  • 330. Barham WB, Church P, Brown JE, Paparello S. Misidentification of Brucella species with use of rapid bacterial identification systems. Clin Infect Dis. 1993;17(6):1068-9. [CrossRef]
  • 331. Arslan H, Korkmaz ME, Kart H, Gül C. Management of Brucella endocarditis of a prosthetic valve. J Infect. 1998;37(1):70-1. [CrossRef]
  • 332. Platt P, Gray J, Carson P. Brucella endocarditis--a successfully treated case. J Infect. 1980;2(3):275-8. [CrossRef]
  • 333. Farid Z, Trabolsi B, Yassin W, Watten RH, Higashi GI. Acute brucellosis presenting as fever of unknown origin (FUO). Trans R Soc Trop Med Hyg. 1980;74(3):402-4. [CrossRef]
  • 334. Kalaycioglu S, Imren Y, Erer D, Zor H, Arman D. Brucella endocarditis with repeated mitral valve replacement. J Card Surg. 2005;20(2):189-92. [CrossRef]
  • 335. Lezaun R, Teruel J, Maître MJ, Artaza M. Brucella endocarditis on double valvular prosthesis. Postgrad Med J. 1980;56(652):119-20. [CrossRef]
  • 336. Alsoub H. Brucella infective endocarditis: a report of four successfully treated patients. Clin Microbiol Infect. 2001;7(7):382-5. [CrossRef]
  • 337. Iglesias A, Nuñez L. Brucella mellitensis endocarditis on a porcine heterograft bioprosthesis. Chest. 1981;80(6):747-9. [CrossRef]
  • 338. Hudson RA. Brucella abortus endocarditis; a case. Circulation. 1957;16(3):411- 3. [CrossRef]
  • 339. Mohandas N, Balasubramanian R, Prasad SB. Can Brucella endocarditis be treated successfully with medical therapy alone? Trop Doct. 2009;39(2):123- 4. [CrossRef]
  • 340. Kanji JN, Saxinger L. Brucella infection at cardiac pacemaker site in a patient who had consumed raw caribou meat in Northern Canada. CMAJ. 2018;190(37):E1108-E1110. [CrossRef]
  • 341. Tasbakan MI, Yamazhan T, Arda B, et al. Tissue culture positive prosthetic aortic valve Brucella endocarditis. Ir J Med Sci. 2006;175(2):84. [CrossRef]
  • 342. Rahman A, Burma O, Felek S, Yekeler H. Atrial septal defect presenting with Brucella endocarditis. Scand J Infect Dis. 2001;33(10):776-7. [CrossRef]
  • 343. Al-Majid FM. Pacemaker lead endocarditis due to Brucellosis. Saudi Med J. 2010;31(4):448-50.
  • 344. Koruk ST, Erdem H, Koruk I, et al. Management of Brucella endocarditis: results of the Gulhane study. Int J Antimicrob Agents. 2012;40(2):145-50. [CrossRef]
  • 345. Reguera JM, Alarcón A, Miralles F, Pachón J, Juárez C, Colmenero JD. Bru- cella endocarditis: clinical, diagnostic, and therapeutic approach. Eur J Clin Microbiol Infect Dis. 2003;22(11):647-50. [CrossRef]
  • 346. Rhodes HM, Williams DN, Hansen GT. Invasive human brucellosis infection in travelers to and immigrants from the Horn of Africa related to the consump- tion of raw camel milk. Travel Med Infect Dis. 2016;14(3):255-60. [CrossRef]
  • 347. Cancan Gursul N, Vardar I, Demirdal T, Gursul E, Ural S, Yesil M. Clinical and microbiological findings of infective endocarditis. J Infect Dev Ctries. 2016;10(5):478-87. [CrossRef]
  • 348. Yetkin U, Yılık L, Özsöyler İ, et al. Brucella endocarditis and its rare compli- cations. Turk Gogus Kalp Dama. 2012;20(1):44-9. [CrossRef]
  • 349. Yıldız F, Bayram E, Kelle B, Erken E. Brucella endocarditis presenting with findings resembling vasculitis. Arch Rheumatol. 2015;30(1):79-82. [CrossRef]
  • 350. Şimşek-Yavuz S, Akar AR, Aydoğdu S, et al. [Diagnosis, treatment and pre- vention of infective endocarditis: Turkish consensus report]. Klimik Derg. 2019; 32(Suppl. 1): 2-116. Turkish. [CrossRef]
  • 351. Bayindir Y, Sonmez E, Aladag A, Buyukberber N. Comparison of five anti- microbial regimens for the treatment of brucellar spondylitis: a prospective, randomized study. J Chemother. 2003;15(5):466-71. [CrossRef]
  • 352. Buzgan T, Karahocagil MK, Irmak H, et al. Clinical manifestations and com- plications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14(6):e469-78. [CrossRef]
  • 353. Colmenero JD, Ruiz-Mesa JD, Plata A, et al. Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis. Clin Infect Dis. 2008;46(3):426-33. [CrossRef]
  • 354. Jia B, Zhang F, Lu Y, et al. The clinical features of 590 patients with brucellosis in Xinjiang, China with the emphasis on the treatment of complications. PLoS Negl Trop Dis. 2017;11(5):e0005577. [CrossRef]
  • 355. Ulu-Kilic A, Karakas A, Erdem H, et al. Update on treatment options for spinal brucellosis. Clin Microbiol Infect. 2014;20(2):75-82. [CrossRef]
  • 356. Mermut G, Ozgenç O, Avcı M, et al. Clinical, diagnostic and therapeutic approaches to complications of brucellosis: an experience of 12 years. Med Princ Pract. 2012;21(1):46-50. [CrossRef]
  • 357. Alp E, Koc RK, Durak AC, et al. Doxycycline plus streptomycin versus ci- profloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]. BMC Infect Dis. 2006;6:72. [CrossRef]
  • 358. El Miedany YM, El Gaafary M, Baddour M, Ahmed I. Human brucellosis: do we need to revise our therapeutic policy? J Rheumatol. 2003;30(12):2666-72.
  • 359. Solera J, Lozano E, Martínez-Alfaro E, Espinosa A, Castillejos ML, Abad L. Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis. 1999;29(6):1440-9. [CrossRef]
  • 360. Yilmaz E, Parlak M, Akalin H, et al. Brucellar spondylitis: review of 25 cases. J Clin Rheumatol. 2004;10(6):300-7. [CrossRef]
  • 361. Ioannou S, Karadima D, Pneumaticos S, et al. Efficacy of prolonged antimi- crobial chemotherapy for brucellar spondylodiscitis. Clin Microbiol Infect. 2011;17(5):756-62. [CrossRef]
APA Şimşek-Yavuz S, Xu C, Benli A, ateş c, AYDIN M, Aygün G, Azap A, Azap Ö, basaran s, Demirturk N, Ergönül Ö, kocagül çelikbaş a, Kuscu F, Sarıcaoğlu E, SAYIN KUTLU S, Turker N, Türkoğlu Yılmaz E (2023). Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. , 86 - 123. 10.36519/kd.2023.4576
Chicago Şimşek-Yavuz Serap,Xu Chengcheng,Benli Aysun,ateş can,AYDIN MEHTAP,Aygün Gökhan,Azap Alpay,Azap Özlem Kurt,basaran seniha,Demirturk Nese,Ergönül Önder,kocagül çelikbaş aysel,Kuscu Ferit,Sarıcaoğlu Elif mukime,SAYIN KUTLU Selda,Turker Nesrin,Türkoğlu Yılmaz Emine Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. (2023): 86 - 123. 10.36519/kd.2023.4576
MLA Şimşek-Yavuz Serap,Xu Chengcheng,Benli Aysun,ateş can,AYDIN MEHTAP,Aygün Gökhan,Azap Alpay,Azap Özlem Kurt,basaran seniha,Demirturk Nese,Ergönül Önder,kocagül çelikbaş aysel,Kuscu Ferit,Sarıcaoğlu Elif mukime,SAYIN KUTLU Selda,Turker Nesrin,Türkoğlu Yılmaz Emine Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. , 2023, ss.86 - 123. 10.36519/kd.2023.4576
AMA Şimşek-Yavuz S,Xu C,Benli A,ateş c,AYDIN M,Aygün G,Azap A,Azap Ö,basaran s,Demirturk N,Ergönül Ö,kocagül çelikbaş a,Kuscu F,Sarıcaoğlu E,SAYIN KUTLU S,Turker N,Türkoğlu Yılmaz E Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. . 2023; 86 - 123. 10.36519/kd.2023.4576
Vancouver Şimşek-Yavuz S,Xu C,Benli A,ateş c,AYDIN M,Aygün G,Azap A,Azap Ö,basaran s,Demirturk N,Ergönül Ö,kocagül çelikbaş a,Kuscu F,Sarıcaoğlu E,SAYIN KUTLU S,Turker N,Türkoğlu Yılmaz E Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. . 2023; 86 - 123. 10.36519/kd.2023.4576
IEEE Şimşek-Yavuz S,Xu C,Benli A,ateş c,AYDIN M,Aygün G,Azap A,Azap Ö,basaran s,Demirturk N,Ergönül Ö,kocagül çelikbaş a,Kuscu F,Sarıcaoğlu E,SAYIN KUTLU S,Turker N,Türkoğlu Yılmaz E "Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023." , ss.86 - 123, 2023. 10.36519/kd.2023.4576
ISNAD Şimşek-Yavuz, Serap vd. "Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023". (2023), 86-123. https://doi.org/10.36519/kd.2023.4576
APA Şimşek-Yavuz S, Xu C, Benli A, ateş c, AYDIN M, Aygün G, Azap A, Azap Ö, basaran s, Demirturk N, Ergönül Ö, kocagül çelikbaş a, Kuscu F, Sarıcaoğlu E, SAYIN KUTLU S, Turker N, Türkoğlu Yılmaz E (2023). Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. Klimik Dergisi, 36(2), 86 - 123. 10.36519/kd.2023.4576
Chicago Şimşek-Yavuz Serap,Xu Chengcheng,Benli Aysun,ateş can,AYDIN MEHTAP,Aygün Gökhan,Azap Alpay,Azap Özlem Kurt,basaran seniha,Demirturk Nese,Ergönül Önder,kocagül çelikbaş aysel,Kuscu Ferit,Sarıcaoğlu Elif mukime,SAYIN KUTLU Selda,Turker Nesrin,Türkoğlu Yılmaz Emine Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. Klimik Dergisi 36, no.2 (2023): 86 - 123. 10.36519/kd.2023.4576
MLA Şimşek-Yavuz Serap,Xu Chengcheng,Benli Aysun,ateş can,AYDIN MEHTAP,Aygün Gökhan,Azap Alpay,Azap Özlem Kurt,basaran seniha,Demirturk Nese,Ergönül Önder,kocagül çelikbaş aysel,Kuscu Ferit,Sarıcaoğlu Elif mukime,SAYIN KUTLU Selda,Turker Nesrin,Türkoğlu Yılmaz Emine Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. Klimik Dergisi, vol.36, no.2, 2023, ss.86 - 123. 10.36519/kd.2023.4576
AMA Şimşek-Yavuz S,Xu C,Benli A,ateş c,AYDIN M,Aygün G,Azap A,Azap Ö,basaran s,Demirturk N,Ergönül Ö,kocagül çelikbaş a,Kuscu F,Sarıcaoğlu E,SAYIN KUTLU S,Turker N,Türkoğlu Yılmaz E Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. Klimik Dergisi. 2023; 36(2): 86 - 123. 10.36519/kd.2023.4576
Vancouver Şimşek-Yavuz S,Xu C,Benli A,ateş c,AYDIN M,Aygün G,Azap A,Azap Ö,basaran s,Demirturk N,Ergönül Ö,kocagül çelikbaş a,Kuscu F,Sarıcaoğlu E,SAYIN KUTLU S,Turker N,Türkoğlu Yılmaz E Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. Klimik Dergisi. 2023; 36(2): 86 - 123. 10.36519/kd.2023.4576
IEEE Şimşek-Yavuz S,Xu C,Benli A,ateş c,AYDIN M,Aygün G,Azap A,Azap Ö,basaran s,Demirturk N,Ergönül Ö,kocagül çelikbaş a,Kuscu F,Sarıcaoğlu E,SAYIN KUTLU S,Turker N,Türkoğlu Yılmaz E "Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023." Klimik Dergisi, 36, ss.86 - 123, 2023. 10.36519/kd.2023.4576
ISNAD Şimşek-Yavuz, Serap vd. "Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023". Klimik Dergisi 36/2 (2023), 86-123. https://doi.org/10.36519/kd.2023.4576